{{Rsnum
|rsid=2053044
|Gene=ADRB2
|Chromosome=5
|position=148825809
|Orientation=plus
|GMAF=0.3669
|Gene_s=ADRB2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 46.0 | 29.2
| HCB | 9.6 | 42.6 | 47.8
| JPT | 2.7 | 23.9 | 73.5
| YRI | 21.1 | 43.5 | 35.4
| ASW | 14.0 | 59.6 | 26.3
| CHB | 9.6 | 42.6 | 47.8
| CHD | 7.3 | 33.9 | 58.7
| GIH | 5.0 | 44.6 | 50.5
| LWK | 30.9 | 50.0 | 19.1
| MEX | 1.7 | 36.2 | 62.1
| MKK | 13.5 | 51.3 | 35.3
| TSI | 13.7 | 52.9 | 33.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22416031
|Title=Genetic variation in the beta-2 adrenergic receptor is associated with chronic musculoskeletal complaints in adolescents
}}

{{PMID Auto
|PMID=19284637
|Title=Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}